Free Trial

ESSA Pharma (EPIX) Stock Price, News & Analysis

ESSA Pharma logo
$1.70 -0.03 (-2.02%)
As of 07/2/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About ESSA Pharma Stock (NASDAQ:EPIX)

Key Stats

Today's Range
$1.67
$1.74
50-Day Range
$1.61
$1.82
52-Week Range
$1.40
$7.88
Volume
74,483 shs
Average Volume
339,438 shs
Market Capitalization
$75.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
Consensus Rating
Hold

Company Overview

ESSA Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
40th Percentile Overall Score

EPIX MarketRank™: 

ESSA Pharma scored higher than 40% of companies evaluated by MarketBeat, and ranked 725th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ESSA Pharma has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    ESSA Pharma has received no research coverage in the past 90 days.

  • Read more about ESSA Pharma's stock forecast and price target.
  • Earnings Growth

    Earnings for ESSA Pharma are expected to grow in the coming year, from ($0.42) to ($0.17) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ESSA Pharma is -2.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ESSA Pharma is -2.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    ESSA Pharma has a P/B Ratio of 0.60. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about ESSA Pharma's valuation and earnings.
  • Percentage of Shares Shorted

    1.92% of the float of ESSA Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    ESSA Pharma has a short interest ratio ("days to cover") of 4.8.
  • Change versus previous month

    Short interest in ESSA Pharma has recently increased by 4.81%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    ESSA Pharma does not currently pay a dividend.

  • Dividend Growth

    ESSA Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.92% of the float of ESSA Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    ESSA Pharma has a short interest ratio ("days to cover") of 4.8.
  • Change versus previous month

    Short interest in ESSA Pharma has recently increased by 4.81%, indicating that investor sentiment is decreasing.
  • News Sentiment

    ESSA Pharma has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.
  • Search Interest

    1 people have searched for EPIX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ESSA Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    15.50% of the stock of ESSA Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    75.12% of the stock of ESSA Pharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about ESSA Pharma's insider trading history.
Receive EPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter.

EPIX Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

EPIX Stock Analysis - Frequently Asked Questions

ESSA Pharma's stock was trading at $1.79 at the beginning of the year. Since then, EPIX shares have decreased by 5.0% and is now trading at $1.70.
View the best growth stocks for 2025 here
.

ESSA Pharma Inc. (NASDAQ:EPIX) released its earnings results on Thursday, May, 8th. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.19) by $0.05.

Shares of EPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ESSA Pharma investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Meta Platforms (META), Jabil (JBL), Builders FirstSource (BLDR) and CymaBay Therapeutics (CBAY).

Company Calendar

Last Earnings
5/08/2025
Today
7/02/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EPIX
Employees
50
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.00
High Stock Price Target
$2.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+17.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$28.54 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$2.81 per share
Price / Book
0.60

Miscellaneous

Free Float
37,509,000
Market Cap
$75.46 million
Optionable
Optionable
Beta
1.56

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:EPIX) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners